在免疫检查点抑制剂治疗后,皮下泛炎类T细胞淋巴瘤的发展

Tommy Y Yu1, Zartash Gul2, Alicia M Hunt3

  • 1Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, USA.

Cureus
|September 16, 2024
PubMed
概括

程序死亡1 (PD-1) 抑制剂,如尼沃卢马布治疗黑色素瘤,但可能引起副作用. 一个罕见的案例表明,这些药物也可能触发二次皮下泛尼古炎类T细胞淋巴瘤 (SPTCL).